Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
GLP-1 drugs may reduce: Frequency of drinking Volume per occasion Desire to drink What this means across the three-tier system Suppliers Monitor changes in premium product demand Evaluate opportunities in lower-ABV and alternative beverages Distributors Watch for shifts in order frequency and product mix Identify regional differences tied to demographics and health trends Retailers On-premise: fewer drinks per visit Off-premise: smaller baskets and substitution effects Why this is a data problem If youre in beverage alcohol, this is a trend you wont see in your dashboardbut you will see it in your data
Researchers also taking compounds like tirzepatide with B12 , tirzepatide with glycine , semaglutide with L-carnitine , or other metabolic cofactors should review their complete supplement and medication list for CYP450 considerations
Abadilla, K
The catch: requires baseline labs and a video visit, adding about a week, and the first-month rate is a teaser
The Journal of Nutritional Biochemistry, 11 (2), 109113
